Holen Sie sich die Stockscreener-App
29.79
0.63%
-0.19
Handel nachbörslich:
30.35
0.56
+1.88%
Schlusskurs vom Vortag:
$29.98
Offen:
$29.87
24-Stunden-Volumen:
1.06M
Relative Volume:
1.06
Marktkapitalisierung:
$1.46B
Einnahmen:
$96.21M
Nettoeinkommen (Verlust:
$-12.13M
KGV:
-95.18
EPS:
-0.313
Netto-Cashflow:
$10.64M
1W Leistung:
+2.41%
1M Leistung:
+3.91%
6M Leistung:
+19.26%
1J Leistung:
+31.93%
1-Tages-Spanne:
$29.63
$30.17
1-Wochen-Bereich:
$28.54
$32.23
52-Wochen-Spanne:
$17.86
$32.23
Biolife Solutions Inc Stock (BLFS) Company Profile
Firmenname
Biolife Solutions Inc
Sektor
Telefon
(425) 401-1400
Adresse
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Compare BLFS vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
29.79 | 1.46B | 96.21M | -12.13M | 10.64M | -0.313 |
ISRG
Intuitive Surgical Inc
|
356.83 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
158.92 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.70 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.28 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
203.08 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2024-09-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-11 | Eingeleitet | Craig Hallum | Buy |
| 2022-04-25 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-10-19 | Eingeleitet | B. Riley Securities | Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-05-14 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-03-23 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-18 | Eingeleitet | Cowen | Outperform |
| 2020-08-11 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-07-08 | Bestätigt | Maxim Group | Buy |
| 2020-02-24 | Eingeleitet | Lake Street | Buy |
| 2020-02-19 | Eingeleitet | The Benchmark Company | Buy |
| 2020-02-06 | Fortgesetzt | B. Riley FBR | Buy |
| 2020-01-08 | Eingeleitet | Stephens | Overweight |
| 2019-11-21 | Eingeleitet | Oppenheimer | Outperform |
| 2019-07-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2017-11-10 | Bestätigt | Maxim Group | Buy |
| 2017-09-19 | Bestätigt | Maxim Group | Buy |
| 2017-07-05 | Hochstufung | Janney | Neutral → Buy |
| 2017-03-10 | Bestätigt | Maxim Group | Buy |
| 2017-01-19 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Biolife Solutions Inc Aktie (BLFS) Neueste Nachrichten
BLFS|BioLife Solutions Inc|Price:29.950|Chg%:-0.030 - TradingKey
BioLife Solutions Inc (BLFS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BLFS|BioLife Solutions Inc|Price:29.980|Chg%:-0.790 - TradingKey
BioLife Solutions Inc (BLFS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioLife Solutions, Inc. Revenue Breakdown – GETTEX:BJX1 - TradingView
BioLife Solutions Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioLife Solutions, Inc.BLFS - The Malone Telegram
Repligen Corporation to Acquire BioLife Solutions for $1.5 Billion, Boosting Cell Therapy Market Presence - Kalkine Media
Repligen to buy BioLife Solutions (NASDAQ: BLFS) in $1.5B cash-and-stock deal - Stock Titan
BioLife Solutions Inc (BLFS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioLife Solutions, Inc. (BLFS) Stock Forecasts - Yahoo Finance
BIOLIFE SOLUTIONS INC : JEFFERIES CUTS TO HOLD FROM BUY; RAISES TARGET PRICE TO $31 FROM $30 - Bitget
Repligen Strengthens Cell Therapy Portfolio With BioLife Acquisition - Sahm
Repligen to Expand Cell Therapy Capabilities With BioLife Buyout - TradingView
Jefferies Downgrades BioLife Solutions to Hold From Buy, Adjusts Price Target to $31 From $30 - Moomoo
BIOLIFE SOLUTIONS INC : TD COWEN CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $31 FROM $33 - Bitget
Bothell firm fetches $1.5 billion in acquisition by Massachusetts company - The Business Journals
Repligen Corporation (RGEN) BioLife Solutions, Inc.,M&A CallSlideshow (NASDAQ:RGEN) 2026-07-23 - Seeking Alpha
Repligen to Acquire BioLife Solutions for $1.5 Billion, Expanding Leadership in Cell Therapy Market - Minichart
BioLife Solutions Inc (BLFS) Stock Up 6.8% but GF Value Says Ove - GuruFocus
BioLife Solutions Cut to Hold From Buy by Lake Street - Moomoo
BioLife Solutions to Be Acquired by Repligen Corporation - TipRanks
Repligen to Acquire Bothell's BioLife Solutions in $1.5B Deal - 425business.com
BioLife Solutions to Be Acquired by Repligen for $11.25 Cash Plus 0.1442 Share Per Share - TradingView
Repligen to buy BioLife Solutions (NASDAQ: BLFS) in $1.5B cash-stock deal - Stock Titan
Repligen to Acquire BioLife Solutions for $11.25 per Share Plus Stock, Enhancing Cell Processing Capabilities - Kalkine Media
Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach - Yahoo Finance
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (NASDAQ: BLFS) - PR Newswire
Repligen targets cell therapy expansion as Waltham firm inks $1.5 billion acquisition - The Business Journals
BioLife Solutions downgraded to Hold amid $1.5B Repligen acquisition and shareholder fairness probe - Pluang
Repligen to Acquire BioLife Solutions in $1.5 Billion Cash-and-Stock Deal, Expanding Into Cell Therapy - finance.biggo.com
Repligen Corporation entered into an agreement and plan of merger to acquire BioLife Solutions, Inc. for approximately $1.6 billion. - marketscreener.com
Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price for Public Shareholders - PR Newswire
Repligen buys BioLife Solutions for $1.5 billion - grafa.com
Repligen to buy BioLife Solutions for USD 1.5 billion in cash-and-stock deal - Bitget
Repligen beefs up cell therapy business with $1.5 billion deal for BioLife - Reuters
Repligen Announces Acquisition of BioLife Solutions in $11.25 Per Share Cash and Stock Deal - Kalkine Media
Repligen to Acquire BioLife Solutions in Cash and Stock Merger Valued at $11.25 Per Share - Kalkine Media
What's Going on With Repligen Stock Wednesday?Repligen (NASDAQ:RGEN), BioLife Solutions (NASDAQ:BLFS) - Benzinga
BLFS Stock Alert: Halper Sadeh LLC is Investigating Whether BioLife Solutions, Inc. is Obtaining a Fair Price for its Shareholders - New Castle News
Repligen Corp To Acquire BioLife Solutions Transcript - GuruFocus
Repligen to acquire BioLife Solutions for $1.5 billion By Investing.com - Investing.com Nigeria
Repligen to acquire BioLife Solutions for $1.5 billion - Investing.com
Repligen to Acquire BioLife Solutions in $1.5 Billion Cash-and-Stock Deal - marketscreener.com
BioLife SolutionsDeal Expected to Be Accre - Moomoo
Press Release: Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities With Market Leading Biopreservation Media - Moomoo
Goodwin Advises Repligen In Acquisition Of BioLife Solutions For Approximately $1.5 Billion - Mondaq
Form 4 BioLife Solutions Inc For: 21 July By Investing.com - Investing.com Nigeria
BioLife Solutions (NASDAQ: BLFS) CTO has 275 shares withheld for RSU taxes - Stock Titan
Repligen to buy BioLife Solutions (NASDAQ: BLFS) in cash and stock merger - Stock Titan
A Look at BioLife Solutions Inc (BLFS) After 3.7% Decline -- GF Value $28.86 vs Price $29.11 - GuruFocus
Biolife Solutions stock hits 52-week high at 30.03 USD By Investing.com - Investing.com South Africa
Finanzdaten der Biolife Solutions Inc-Aktie (BLFS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.62%
0.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):